Cargando…
Exogenous Surfactant as a Pulmonary Delivery Vehicle for Budesonide In Vivo
BACKGROUND: Lung inflammation is associated with many respiratory conditions. Consequently, anti-inflammatory medications, like glucocorticoids, have become mainstay intrapulmonary therapeutics. However, their effectiveness for treating inflammation occurring in the alveolar regions of the lung is l...
Autores principales: | Baer, Brandon, McCaig, Lynda, Yamashita, Cory, Veldhuizen, Ruud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587541/ https://www.ncbi.nlm.nih.gov/pubmed/33106891 http://dx.doi.org/10.1007/s00408-020-00399-2 |
Ejemplares similares
-
Optimizing Exogenous Surfactant as a Pulmonary Delivery Vehicle for Chicken Cathelicidin-2
por: Baer, Brandon, et al.
Publicado: (2020) -
The effects of exogenous surfactant administration on ventilation-induced inflammation in mouse models of lung injury
por: Puntorieri, Valeria, et al.
Publicado: (2013) -
Maternal protein restriction during perinatal life affects lung mechanics and the surfactant system during early postnatal life in female rats
por: Khazaee, Reza, et al.
Publicado: (2019) -
DDEL-03. The use of programmable valves as a vehicle for intrathecal chemotherapy delivery in infants with CNS tumors and hydrocephalus.
por: Dvir, Rina, et al.
Publicado: (2022) -
Optimizing and Evaluating the Transdermal Permeation of Hydrocortisone Transfersomes Formulation Based on Digital Analysis of the In Vitro Drug Release and Ex Vivo Studies
por: Abdelwahd, Asmae, et al.
Publicado: (2022)